Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
HIV Clinical Trials|April 19, 2011
Factors associated with complete adherence to HIV combination antiretroviral therapyTimothy Juday, Shaloo Gupta, Kristy Grimm, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2015
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCVSammy Saab, Yuri S Gonzalez, Caroline Huber, et al.
Health Affairs (Project Hope)|March 5, 2014
The prospect of a generation free of HIV may be within reach if the right policy decisions are madeDana P Goldman, Timothy Juday, Mark T Linthicum, et al.
Journal of Medical Economics|February 9, 2013
Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapyMachaon Bonafede, Timothy Juday, Greg Lenhart, et al.
AIDS Care|March 23, 2013
Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USAGary Schneider, Timothy Juday, Charles Wentworth, et al.
Health Affairs (Project Hope)|March 5, 2014
Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009Dana P Goldman, Timothy Juday, Daniel Seekins, et al.
Pageof 4